Selective Laser Trabeculoplasty (SLT)
Treatment for Glaucoma
Effectiveness
80%
Safety Score
80%
Clinical Trials
63
Participants
30K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
80
DangerousModerateSafe
Treatment Details
Time to Effect
Hours to days (maximal 4-6 weeks)
Treatment Duration
Effect typically lasts 1-5 years, repeatable
Evidence Quality
HIGHConfidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$50
Monitoring:$600
Side Effect Mgmt:$20
Total Annual:$1,003
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$5,000/QALY
QALYs Gained
0.7
Outcome-Based Costs
Cost per Responder
$1,337
Comparison vs Topical Prostaglandin Analog
Cost Difference
$-50/year
Less expensive
QALY Difference
+0.10 QALYs
Better outcomes
Dominance
DOMINATESBetter + cheaper
Selective Laser Trabeculoplasty (SLT) Outcomes
for Glaucoma
Efficacy Outcomes
Overall Effectiveness
+80%
Response Rate
+75%
Common Side Effects
Transient intraocular pressure spike
+7%
Mild ocular inflammation
+6%
Pain/discomfort during procedure
+3%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
4 active trials recruiting for Selective Laser Trabeculoplasty (SLT) in Glaucoma
Direct vs Standard SLT for Glaucoma: A Noninferiority Trial
NCT07408154NOT YET RECRUITINGPHASE4
172 participants
INTERVENTIONAL
Charleston, United States
Started: Apr 1, 2026
Optimal Treatment Protocol for Selective Laser Trabeculoplasty
NCT03798223ACTIVE NOT RECRUITINGNA
400 participants
INTERVENTIONAL
Borås, Sweden +3 more
Started: Jan 10, 2019
Optimal Treatment Protocol for Selective Laser Trabeculoplasty - Repeat Trial
NCT05159960ENROLLING BY INVITATIONNA
400 participants
INTERVENTIONAL
Skövde, Sweden +1 more
Started: Jan 10, 2022
Clarifying the Optimal Application of SLT Therapy Trial
NCT04967989RECRUITINGPHASE3
790 participants
INTERVENTIONAL
Laguna Hills, United States +28 more
Started: Sep 7, 2021
Completed Clinical Trials
9 completed trials for Selective Laser Trabeculoplasty (SLT) in Glaucoma
The Effect of Selective Laser Trabeculoplasty (SLT) on Ocular Rigidity
NCT01247831COMPLETEDNA
150 participants
INTERVENTIONAL
Dresden, Germany
Started: Nov 1, 2010
Efficacy of Selective Laser Trabeculoplasty Targeting Nasal Versus Inferior 180-degree
NCT06851546COMPLETEDNA
13 participants
INTERVENTIONAL
Rochester, United States +1 more
Started: Jan 6, 2025
Is the Reduction in IOP After Treatment of 180 Degrees Equivalent to Treatment of 360 Degrees With SLT?
NCT03529591COMPLETEDNA
40 participants
INTERVENTIONAL
London, Canada
Started: Jun 29, 2018
EXTERNAL SLT Treatment in Patients With Uncontrolled OPEN ANGLE GLAUCOMA
NCT01384149COMPLETEDPHASE1
32 participants
INTERVENTIONAL
Beer Yaakov, Israel +2 more
Started: Sep 1, 2011
Safety and Effectiveness of VISULAS Green Selective Laser Trabeculoplasty (SLT)
NCT04519814COMPLETEDNA
37 participants
INTERVENTIONAL
Dresden, Germany +4 more
Started: Jun 30, 2020
The Effects of DSLT and SLT on the Corneal Endothelium: A GLAUrious Trial Sub-Study
NCT04758598COMPLETEDNA
20 participants
INTERVENTIONAL
Tbilisi, Georgia
Started: Mar 1, 2021
Micropulse Laser Trabeculoplasty (MLT) Versus Selective Laser Trabeculoplasty (SLT) for Treatment of Open Angle Glaucoma
NCT01956942COMPLETEDNA
81 participants
INTERVENTIONAL
Washington D.C., United States
Started: Aug 1, 2013
Selective Laser Trabeculoplasty After Failed Phacoemulsification With Eximer Laser Trabeculectomy
NCT02434250COMPLETEDNA
203 participants
INTERVENTIONAL
Zurich, Switzerland
Started: May 1, 2015
Comparison of Bimatoprost Sustained Release (SR) to Selective Laser Trabeculoplasty (SLT) in Adults With Open-Angle Glaucoma or Ocular Hypertension
NCT02507687COMPLETEDPHASE3
240 participants
INTERVENTIONAL
Dothan, United States +94 more
Started: Aug 27, 2015
Showing 20 of 68 total trials